Qube Research & Technologies LTD Shockwave Medical, Inc. Transaction History

Qube Research & Technologies LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$191.17 - $325.63 $740,592 - $1.26 Million	3,874 Added 2391.36%	4,036 $1.31 Million
Q4 2023 Feb 13, 2024	SELL	$160.99 - $215.69 $1.98 Million - $2.65 Million	-12,277 Reduced 98.7%	162 $30,000
Q3 2023 Nov 13, 2023	SELL	$194.33 - $283.97 $15.7 Million - $23 Million	-80,857 Reduced 86.67%	12,439 $2.48 Million
Q2 2023 Aug 14, 2023	BUY	$223.05 - $302.68 $20.8 Million - $28.2 Million	93,296 New	93,296 $26.6 Million
Q4 2022 Feb 14, 2023	BUY	$204.38 - $296.82 $5.59 Million - $8.13 Million	27,374 Added 74.63%	64,053 $13.2 Million
Q3 2022 Nov 14, 2022	BUY	$195.21 - $310.53 $7.16 Million - $11.4 Million	36,679 New	36,679 $10.2 Million
Q3 2021 Nov 12, 2021	SELL	$163.99 - $235.57 $2.94 Million - $4.23 Million	-17,945 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$131.45 - $201.49 $2.36 Million - $3.62 Million	17,945 New	17,945 $3.41 Million
Q1 2021 May 14, 2021	SELL	$92.73 - $142.05 $258,809 - $396,461	-2,791 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$67.44 - $103.72 $188,225 - $289,482	2,791 New	2,791 $289,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.